Couldn’t. Sad to see that the company is not publishing the transcript of the AGM discussions or the analysts meet. Holding on to the investment on the basis of the positive outlook of the CMD’s address, 50% growth expectations for Manchester unit, 20% overall growth and the hope that any challenge on margins may be offset by topline growth… others please comment on the outlook after AGM.
Posts tagged Value Pickr
Neuland Laboratories Limited – Transformation towards niche APIs? (27-09-2024)
FDA has approved BMS Cobenfy (KarXT), First New Schizophrenia Drug in Seven Decades.
Advait Infratech: A detailed analysis (27-09-2024)
Thanks for sharing, but I fail to understand how is this profitable?
Net cost is 25k. So how is this profitable? You have considered profit of just 50$ /mw.
Hindustan Foods (27-09-2024)
Hindustan Foods shares up 2% on merger with promoter‐owned entity
52 week highs and all time highs strategy (27-09-2024)
MARUTI SUZUKI INDIA LTD is nearing its all-time high record.
Weekly
Daily
Disclaimer: No Positions, This is not a recommendation to buy or sell and shared purely for educational purpose.
Stock Alpha: ChatGPT for Equity Research (27-09-2024)
Hi Sandeep- thanks for checking out Stock Alpha. While Screener is great at giving you structured tables of data & brief summaries of transcripts, our users still spent hours & weeks reading long annual reports, earnings calls & investor decks
A lot of company context & operational information, along with strategy details are captured in these documents which Screener fails to deliver
Using Stock Alpha- you have an Assistant available with you 24 x 7 that has context on hundreds of companies & their stock filings & can answer questions related to help you make better informed investment decisions
Would love your feedback 
Neuland Laboratories Limited – Transformation towards niche APIs? (27-09-2024)
KUDOS TO NEULAND LABS AND BMS
Neuland Laboratories Limited – Transformation towards niche APIs? (26-09-2024)
US FDA has approved BMS’ KarXT under the brand name Cobenfy.
